SPECTROLYSE HEPARIN (ANTI-IIA)— 510(k) K972209
Substantially EquivalentMedical Diagnostic Technologies, Inc.
FDA 510(k) clearance K972209 for SPECTROLYSE HEPARIN (ANTI-IIA), Substantially Equivalent on 1997-08-12. Applicant: Medical Diagnostic Technologies, Inc.. Device class: 2.
Clearance details
- Applicant
- Medical Diagnostic Technologies, Inc.
- Product code
- Product code KFF
- Device class
- Class 2
- Regulation
- 21 CFR 864.7525
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Ventura, CA, US
Recent devices under product code KFF
view all- K260214 — STA® - Liquid Anti-Xa
- K213464 — HemosIL Liquid Anti-Xa
- K162540 — INNOVANCE(r) Heparin Reagents, INNOVANCE(r) Heparin Calibrator, INNOVANCE(r) Heparin UF and Heparin LMW Controls
- K111822 — STA(R) - LIQUID ANTI-XA, MULTI HEP CALIBRATOR, QUALITY HNF / UFH, QUALITY HBPM / LMWH
- K090209 — HEMOSIL LIQUID HEPARIN, HEPARIN CALIBRATORS AND LMW AND UF HEPARIN CONTROLS
More clearances from Medical Diagnostic Technologies, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.